Synthetic antigen presenting matrix
US6461867B1 · kind B1 · utility
15Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1997 |
| Grant date | Oct 8, 2002 |
| Priority date | — |
| Expiry date | Sep 8, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/827
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Materials and methods of activating T lymphocytes with specificity for particular antigenic peptides are described, as well as the use of activated T lymphocytes in vitro for the treatment of a variety of disease conditions. In particular, a synthetic antigen presenting matrix for activating T lymphocytes to a specific peptide is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.